All News

Hospitalization for COVID-19 was associated with higher long-term risks of death, adverse health outcomes, and significant cumulative excess DALYs vs influenza.

Fever and confusion bring the young man in his twenties to the ED; roommates relate he's been weak and flu-like for 5 days. What's your diagnosis?

Get GOLD Report updates at-a-glance on initiating pharmacotherapy, avoiding exacerbations, treating dyspnea, how to approach using ICS, plus other topics.

Your daily dose of the clinical news you may have missed.

Get a quick look at 13 of the many FDA-approved drugs in 2023 for conditions commonly seen in primary care.

Approval of the application would extend the current Arexvy indication for prevention of RSV in adults aged 60 years and older; a June 2024 PDUFA date is set.

Your daily dose of the clinical news you may have missed.

Amgen's investigational maridebart cafraglutide in a phase 1 trial led to durable weight reduction following less frequent and lower doses, the company said.

Results showed nearly one-third of hospitalizations for acute respiratory illness among children aged <5 years were associated with RSV.

Your daily dose of the clinical news you may have missed.

Influenza continues to rage in some parts of the US; try these 4 quick questions on vaccines you may or may not have on hand.

Updates in the Global Initiative for Obstructive Lung Disease report include using spirometry values in diagnosis and optimizing inhaled pharmacotherapy.

Using FIB-4 index first to screen for cirrhosis may lead to clinicians missing 48% of cases, according to a recent study.

Your daily dose of the clinical news you may have missed.

Preventive health screenings have yet to rebound to pre-COVID-19 levels and Asian adults appear to have fallen behind more than other racial/ethnic groups, a new study finds.

Mean placebo-adjusted SBP change from baseline at 36 weeks was 8.6 mm Hg in adults with obesity, according to authors of the SURMOUNT-1 ABPM substudy.

Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.

Access to methadone and buprenorphine treatment may be easier and incentive to continue treatment could start at home, using telehealth, according to HHS.